138 related articles for article (PubMed ID: 22213210)
21. Efficacy and toxicity of reirradiation using intensity-modulated radiotherapy for recurrent or second primary head and neck cancer.
Sher DJ; Haddad RI; Norris CM; Posner MR; Wirth LJ; Goguen LA; Annino D; Balboni T; Allen A; Tishler RB
Cancer; 2010 Oct; 116(20):4761-8. PubMed ID: 20572036
[TBL] [Abstract][Full Text] [Related]
22. Short versus conventional preoperative radiotherapy of rectal cancer: indications.
Klenova A; Georgiev R; Kurtev P; Kurteva G
J BUON; 2007; 12(2):227-32. PubMed ID: 17600877
[TBL] [Abstract][Full Text] [Related]
23. Is re-irradiation effective in symptomatic local recurrence of non small cell lung cancer patients? A single institution experience and review of the literature.
Cetingoz R; Arican-Alicikus Z; Nur-Demiral A; Durmak-Isman B; Bakis-Altas B; Kinay M
J BUON; 2009; 14(1):33-40. PubMed ID: 19373944
[TBL] [Abstract][Full Text] [Related]
24. Preoperative radiotherapy improves outcome in recurrent rectal cancer.
Vermaas M; Ferenschild FT; Nuyttens JJ; Marinelli AW; Wiggers T; van der Sijp JR; Verhoef C; Graveland WJ; Eggermont AM; de Wilt JH
Dis Colon Rectum; 2005 May; 48(5):918-28. PubMed ID: 15785886
[TBL] [Abstract][Full Text] [Related]
25. Reirradiation for locally recurrent nasopharyngeal carcinoma: treatment results and prognostic factors.
Oksüz DC; Meral G; Uzel O; Cağatay P; Turkan S
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):388-94. PubMed ID: 15380570
[TBL] [Abstract][Full Text] [Related]
26. Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer.
Deville C; Both S; Hwang WT; Tochner Z; Vapiwala N
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):763-72. PubMed ID: 20171807
[TBL] [Abstract][Full Text] [Related]
27. Treatment of recurrent bronchial carcinoma: the role of high-dose-rate endoluminal brachytherapy.
Hauswald H; Stoiber E; Rochet N; Lindel K; Grehn C; Becker HD; Debus J; Harms W
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):373-7. PubMed ID: 19836162
[TBL] [Abstract][Full Text] [Related]
28. Local excision following pre-operative chemoradiotherapy-induced downstaging for selected cT3 distal rectal cancer.
Yeo SG; Kim DY; Kim TH; Kim SY; Chang HJ; Park JW; Choi HS; Oh JH
Jpn J Clin Oncol; 2010 Aug; 40(8):754-60. PubMed ID: 20457724
[TBL] [Abstract][Full Text] [Related]
29. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
[TBL] [Abstract][Full Text] [Related]
30. Reirradiation as a component of the multidisciplinary management of locally recurrent breast cancer.
Harkenrider MM; Wilson MR; Dragun AE
Clin Breast Cancer; 2011 Jun; 11(3):171-6. PubMed ID: 21665137
[TBL] [Abstract][Full Text] [Related]
31. Reirradiation Using Carbon Ions in Patients with Locally Recurrent Rectal Cancer at HIT: First Results.
Habermehl D; Wagner M; Ellerbrock M; Büchler MW; Jäkel O; Debus J; Combs SE
Ann Surg Oncol; 2015; 22(6):2068-74. PubMed ID: 25384705
[TBL] [Abstract][Full Text] [Related]
32. Curative surgical resection following reirradiation for recurrent rectal cancer.
Mohiuddin M; Marks GM; Lingareddy V; Marks J
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):643-9. PubMed ID: 9336144
[TBL] [Abstract][Full Text] [Related]
33. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
Thomschke D; Kyau-Ummen B; Halbfass HJ
Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
[TBL] [Abstract][Full Text] [Related]
34. Survival benefit for pediatric patients with recurrent ependymoma treated with reirradiation.
Bouffet E; Hawkins CE; Ballourah W; Taylor MD; Bartels UK; Schoenhoff N; Tsangaris E; Huang A; Kulkarni A; Mabbot DJ; Laperriere N; Tabori U
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1541-8. PubMed ID: 22245198
[TBL] [Abstract][Full Text] [Related]
35. Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies.
Kramer NM; Horwitz EM; Cheng J; Ridge JA; Feigenberg SJ; Cohen RB; Nicolaou N; Sherman EJ; Babb JS; Damsker JA; Langer CJ
Head Neck; 2005 May; 27(5):406-14. PubMed ID: 15719391
[TBL] [Abstract][Full Text] [Related]
36. Reirradiation for head-and-neck cancer: delicate balance between effectiveness and toxicity.
Hoebers F; Heemsbergen W; Moor S; Lopez M; Klop M; Tesselaar M; Rasch C
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e111-8. PubMed ID: 21362581
[TBL] [Abstract][Full Text] [Related]
37. Reirradiation for rectal cancer and surgical resection after ultra high doses.
Mohiuddin M; Lingareddy V; Rakinic J; Marks G
Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1159-63. PubMed ID: 8262842
[TBL] [Abstract][Full Text] [Related]
38. Utilization of interventional radiology in the postoperative management of patients after surgery for locally advanced and recurrent rectal cancer.
Llaguna OH; Calvo BF; Stitzenberg KB; Deal AM; Burke CT; Dixon RG; Stavas JM; Meyers MO
Am Surg; 2011 Aug; 77(8):1086-90. PubMed ID: 21944529
[TBL] [Abstract][Full Text] [Related]
39. Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck.
Spencer SA; Harris J; Wheeler RH; Machtay M; Schultz C; Spanos W; Rotman M; Meredith R; Ang KK
Head Neck; 2008 Mar; 30(3):281-8. PubMed ID: 17764087
[TBL] [Abstract][Full Text] [Related]
40. Palliative reirradiation for recurrent rectal cancer.
Lingareddy V; Ahmad NR; Mohiuddin M
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):785-90. PubMed ID: 9240647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
